Benjamin Budish
Stock Analyst at Barclays
(4.94)
# 32
Out of 4,748 analysts
283
Total ratings
81.52%
Success rate
19.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Budish
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NDAQ Nasdaq | Maintains: Overweight | $96 → $95 | $81.73 | +16.24% | 9 | Jan 30, 2025 | |
| IVZ Invesco | Maintains: Equal-Weight | $18 → $20 | $19.00 | +5.26% | 4 | Jan 29, 2025 | |
| ARES Ares Management | Reinstates: Overweight | $224 | $193.42 | +15.81% | 19 | Jan 27, 2025 | |
| SCHW The Charles Schwab Corporation | Maintains: Overweight | $95 → $96 | $82.06 | +16.99% | 23 | Jan 22, 2025 | |
| IBKR Interactive Brokers Group | Maintains: Overweight | $224 → $231 | $211.25 | +9.35% | 20 | Jan 22, 2025 | |
| VRTS Virtus Investment Partners | Maintains: Underweight | $239 → $221 | $208.87 | +5.81% | 3 | Jan 17, 2025 | |
| VCTR Victory Capital Holdings | Maintains: Equal-Weight | $69 → $70 | $65.28 | +7.23% | 3 | Jan 17, 2025 | |
| TROW T. Rowe Price Group | Maintains: Underweight | $115 → $113 | $114.31 | -1.15% | 5 | Jan 17, 2025 | |
| BEN Franklin Resources | Maintains: Underweight | $21 → $19 | $20.05 | -5.24% | 4 | Jan 17, 2025 | |
| CG The Carlyle Group | Maintains: Overweight | $59 → $60 | $56.35 | +6.48% | 14 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $16 | $13.66 | +17.13% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $199 → $192 | $185.38 | +3.57% | 18 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1,220 → $1,160 | $1,052.61 | +10.20% | 6 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $49 → $54 | $51.15 | +5.57% | 15 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $378 → $379 | $362.02 | +4.69% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $153 → $154 | $127.87 | +20.43% | 6 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $39 | $35.70 | +9.24% | 6 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $260 → $256 | $218.99 | +16.90% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $187 → $179 | $157.22 | +13.85% | 10 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $212 | $204.02 | +3.91% | 10 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $72 → $66 | $63.97 | +3.17% | 12 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $166 → $185 | $166.30 | +11.24% | 14 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $204 → $355 | $291.00 | +21.99% | 23 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $231 → $257 | $232.50 | +10.54% | 13 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $174 → $200 | $171.10 | +16.89% | 19 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $39 → $36 | $39.44 | -8.72% | 4 | Dec 9, 2024 |
Nasdaq
Jan 30, 2025
Maintains: Overweight
Price Target: $96 → $95
Current: $81.73
Upside: +16.24%
Invesco
Jan 29, 2025
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $19.00
Upside: +5.26%
Ares Management
Jan 27, 2025
Reinstates: Overweight
Price Target: $224
Current: $193.42
Upside: +15.81%
The Charles Schwab Corporation
Jan 22, 2025
Maintains: Overweight
Price Target: $95 → $96
Current: $82.06
Upside: +16.99%
Interactive Brokers Group
Jan 22, 2025
Maintains: Overweight
Price Target: $224 → $231
Current: $211.25
Upside: +9.35%
Virtus Investment Partners
Jan 17, 2025
Maintains: Underweight
Price Target: $239 → $221
Current: $208.87
Upside: +5.81%
Victory Capital Holdings
Jan 17, 2025
Maintains: Equal-Weight
Price Target: $69 → $70
Current: $65.28
Upside: +7.23%
T. Rowe Price Group
Jan 17, 2025
Maintains: Underweight
Price Target: $115 → $113
Current: $114.31
Upside: -1.15%
Franklin Resources
Jan 17, 2025
Maintains: Underweight
Price Target: $21 → $19
Current: $20.05
Upside: -5.24%
The Carlyle Group
Jan 13, 2025
Maintains: Overweight
Price Target: $59 → $60
Current: $56.35
Upside: +6.48%
Jan 13, 2025
Maintains: Overweight
Price Target: $15 → $16
Current: $13.66
Upside: +17.13%
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $199 → $192
Current: $185.38
Upside: +3.57%
Jan 13, 2025
Maintains: Overweight
Price Target: $1,220 → $1,160
Current: $1,052.61
Upside: +10.20%
Jan 13, 2025
Maintains: Overweight
Price Target: $49 → $54
Current: $51.15
Upside: +5.57%
Jan 13, 2025
Maintains: Overweight
Price Target: $378 → $379
Current: $362.02
Upside: +4.69%
Jan 13, 2025
Maintains: Overweight
Price Target: $153 → $154
Current: $127.87
Upside: +20.43%
Jan 13, 2025
Maintains: Overweight
Price Target: $35 → $39
Current: $35.70
Upside: +9.24%
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $260 → $256
Current: $218.99
Upside: +16.90%
Jan 13, 2025
Maintains: Overweight
Price Target: $187 → $179
Current: $157.22
Upside: +13.85%
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $220 → $212
Current: $204.02
Upside: +3.91%
Dec 9, 2024
Maintains: Equal-Weight
Price Target: $72 → $66
Current: $63.97
Upside: +3.17%
Dec 9, 2024
Maintains: Overweight
Price Target: $166 → $185
Current: $166.30
Upside: +11.24%
Dec 9, 2024
Maintains: Equal-Weight
Price Target: $204 → $355
Current: $291.00
Upside: +21.99%
Dec 9, 2024
Maintains: Equal-Weight
Price Target: $231 → $257
Current: $232.50
Upside: +10.54%
Dec 9, 2024
Maintains: Overweight
Price Target: $174 → $200
Current: $171.10
Upside: +16.89%
Dec 9, 2024
Maintains: Equal-Weight
Price Target: $39 → $36
Current: $39.44
Upside: -8.72%